Aspergillus pseudomembranous tracheitis leading to tracheal cartilage exfoliation: uncommon disease with rare presentation Authors: Jiayue Wang, Jie Huang, Jidong Liu, Xiaowei Cheng Published: 2025 ABSTRACT BackgroundWhile pulmonary aspergillosis constitutes a common fungal infection with typical respiratory manifestations, its association with tracheal cartilage exfoliation is an exceedingly rare complication. This report describes a case in a 55-year-old female, detailing the clinical presentation, therapeutic management, and follow-up to elucidate this unusual disease process.Case presentationA middle-aged diabetic woman presented with cough, wheezing, and sputum. Imaging and bronchoscopy identified a tracheal mass, with biopsy confirming fungal (likely Aspergillus) infection.During intravenous voriconazole treatment, she coughed out a piece of cartilage, confirming tracheal invasion. Follow-up showed tracheal stenosis, granulation tissue, and cartilage destruction.Over the time her symptoms resolved. Follow-up CT showed stable tracheal narrowing, with good recovery.ConclusionDespite improved diagnostics for pulmonary fungal infections, tracheal cartilage exfoliation due to Aspergillus remains a serious concern. The fungus secretes endotoxins and proteases that cause tissue necrosis and cartilage invasion, leading to exfoliation prone to misdiagnosis and life-threatening asphyxia. Therefore, thorough patient education about this risk is essential.Clinical trial numberNot applicable. Introduction The structural integrity of the tracheobronchial tree, essential for airway patency, is conferred by its C-shaped cartilaginous rings. Invasive tracheobronchial aspergillosis (ITBA) with resultant cartilage destruction is a recognized but exceedingly rare complication, with the sparse literature primarily documenting cases in profoundly immunocompromised hosts, such as those undergoing chemotherapy or solid organ transplantation [1]. The pathogenic cascade, driven by fungal proteolytic enzymes and direct hyphal invasion that degrade the cartilaginous matrix, leads to exfoliation and life-threatening airway collapse. Herein, we present a case that underscores a critical knowledge gap: We encountered a case of a 55-year-old female with tracheal cartilage exfoliation resulting from Aspergillus infection. The patient presented with recurrent cough, sputum production, and wheezing. The initial outpatient CT scan showed an atypical patchy shadow in the main bronchus. Bronchoscopy after admission revealed a neoplasm obstructing the lumen. Pathological examination of the biopsy suggested Aspergillus. After a period of treatment, the patient expectorated a tissue mass (Fig. 1). Pathological examination of this expelled foreign body confirmed it to be tracheal cartilage tissue, with the presence of fungal spores, hyphae (suggestive of Aspergillus), and bacterial aggregates. Subsequent follow-up bronchoscopy compared to previous examinations revealed scar stenosis in the airway and destruction of the tracheal cartilage. This case expands the known clinical spectrum of ITBA, challenges the paradigm of its exclusive association with severe immunosuppression, and highlights the need for heightened diagnostic vigilance in all patients with atypical airway symptoms. Case presentation A middle-aged woman presented with a one-month history of recurrent cough, sputum production, and wheezing.She reported no hemoptysis, chest pain, or fever. Her past medical history included diabetes mellitus, which was characterized by inadequately controlled blood glucose. Physical examination revealed no abnormal findings. An outpatient CT scan indicated a patchy shadow in the main trachea (Fig. 2), with no other significant findings. Upon admission, routine blood tests, sputum smear, fungal (1–3)-β-D-glucan, and procalcitonin tests all returned normal results. The initial bronchoscopic examination revealed a neoplasm located 3 cm from the carina, obstructing the airway lumen with necrotic material adherent to its surface (Fig. 3). Biopsy and brush cytology samples were obtained from the neoplasm for pathological and cytological examination. Subsequent histopathological examination with HE staining of the tracheal neoplasm specimen showed fungi with branched sporulation heads under 200x magnification (Fig. 4), morphologically suggestive of Aspergillus infection. ELISA testing for serum Aspergillus antigen yielded a value of 0.14. However, fungal culture of the bronchoalveolar lavage fluid was negative. Based on the pathological findings, intravenous voriconazole antifungal therapy was initiated (loading dose 6 mg/kg q12h IV on day one, followed by 4 mg/kg q12h IV from day two). During treatment, the patient expectorated a tissue mass measuring approximately 3.0 cm x 1.0 cm x 0.5 cm (Fig. 1). Subsequent examination confirmed the expectorated material was cartilage tissue (Fig. 5). A chest CT scan indicated narrowing of the bronchus at the level of the thoracic inlet, with an irregular and slightly enhanced wall (Fig. 6). Bronchoscopy revealed granulation tissue hyperplasia in the trachea, luminal stenosis, destruction of the tracheal cartilage, and visible residual stumps (Fig. 7). The patient’s symptoms improved significantly during hospitalization, and she was discharged. Subsequently, the patient was followed up in the outpatient department. A repeat chest CT in April 2023 showed localized slight narrowing of the main trachea, with the degree of stenosis largely unchanged compared to previous scans (Fig. 8). Concurrent bronchoscopy suggested tracheal stenosis, likely due to granulation tissue (Fig. 9). After re-examination, the patient continued oral voriconazole tablets 200 mg twice daily and recovered well. Fig. 1Tissue expectorated by the patient Tissue expectorated by the patient Fig. 2Chest CT results from the patient’s initial outpatient visit Chest CT results from the patient’s initial outpatient visit Fig. 3Results of the first bronchoscopy on February 21 Results of the first bronchoscopy on February 21 Fig. 4Fungal hyphae morphologic features of Aspergillus were observed on HE staining at 200x magnification Fungal hyphae morphologic features of Aspergillus were observed on HE staining at 200x magnification Fig. 5Biopsy pathology from the first bronchoscopy on February 21 Biopsy pathology from the first bronchoscopy on February 21 Fig. 6Repeat chest CT during outpatient visit on February 28 Repeat chest CT during outpatient visit on February 28 Fig. 7Follow-up bronchoscopy on March 2 Follow-up bronchoscopy on March 2 Fig. 8Repeat chest CT on April 3 Repeat chest CT on April 3 Fig. 9Repeat bronchoscopy on April 4 Repeat bronchoscopy on April 4 Discussion Pulmonary aspergillosis encompasses a range of infectious and non-infectious lung diseases caused by fungi of the genus Aspergillus. The genus Aspergillus belongs to the family Trichocomaceae, phylum Ascomycota. Over 250 species of Aspergillus have been identified to date [2]. Aspergillus is an opportunistic pathogenic fungus; individuals with systemic or local immune deficiencies are susceptible to Aspergillus infection, although it can also cause disease in some healthy individuals. Among the known Aspergillus species, those causing human infections include A. fumigatus, A. flavus, A. terreus, A. niger, as well as the less common A. nidulans and A. ustus [3, 4]. Aspergillus is widely distributed in the natural environment and can be isolated from various sites in the human body. In recent years, the incidence of Invasive Aspergillosis (IA) has been steadily increasing. Conservative estimates suggest approximately 60,000 cases of IA annually in Europe [5], while China has at least 160,000 cases per year [6]. IA is a severe and often fatal infection, with a global mortality rate ranging from 30% to 95%, and reported mortality rates in China between 39% or 100% [7]. The clinical symptoms of Aspergillus infection are diverse and depend on the patient’s immune status [8]. Clinical manifestations following Aspergillus infection primarily include Aspergillus bronchitis and fungal-sensitized asthma, among others. Common symptoms are cough, sputum production, hemoptysis, fever, chest tightness, and shortness of breath. Imaging findings often include scattered nodules, ground-glass opacities (GGO), air crescent sign/cavitation, halo sign/reversed halo sign, peripheral wedge-shaped infarction, and consolidation. Atypical presentations include thickening of the tracheal/bronchial wall (large airways), tree-in-bud opacities (small airways), consolidation and nodules with or without cavitation, and GGO primarily distributed peribronchially (most common), and non-specific infiltrates (most common) [9]. This patient presented primarily with cough, expectoration, and wheezing. Physical examination revealed no abnormal findings. Considering her history of diabetes mellitus, a chest CT scan was warranted. However, the pulmonary imaging findings in this case were atypical, primarily showing a neoplasm within the large airways. Bronchoscopy revealed a neoplasm obstructing the bronchial lumen, with superficial attachment of white, caseous necrotic material. Based on bronchoscopic findings, pseudomembranous bronchitis was highly suspected. In our region, tuberculosis is relatively common, but the patient’s sputum smear for acid-fast bacilli was negative. Secondly, neoplastic lesions could not be completely ruled out; however, no nodules or extrinsic compression stenosis were observed bronchoscopically, and the chest CT showed no evidence of tumor invasion into surrounding tissues. Therefore, bronchoalveolar lavage (BAL) fluid analysis and pathological examination were performed. Unfortunately, no aspergillus grew from the BAL fluid culture, but microscopic examination revealed characteristic aspergillus hyphae, leading to the final diagnosis of aspergillus infection. Following treatment, the lesions stabilized. Subsequent bronchoscopy showed airway stenosis. However, the patient, a farmer from western China, could not afford the high cost of an airway stent and was lost to follow-up during outpatient visits, leaving her subsequent condition unknown. Aspergillus infection can lead to tracheal ulcerative lesions and subsequently extensive pseudomembranous disease. This patient’s imaging indicated abnormal patchy shadows within the large airways, and bronchoscopy suggested an intraluminal neoplasm. The patient spontaneously expectorated a piece of tracheal cartilage, which may be attributed to fungal hyphae penetrating the tissue, causing local infection, inflammation, secondary hemorrhagic infarction, and necrosis [10]. Studies by some scholars have confirmed that fungi, particularly aspergillus, can exhibit osteoinvasive behavior [11], but these primarily describe the phenomenon, with the specific mechanisms remaining unclear. Some literature suggests that aspergillus, especially A. fumigatus, produces proteolytic enzymes [12]. These enzymes are involved in airway inflammation, and infiltration by neutrophils and lymphocytes leads to local suppurative inflammation in the patient’s airways. These factors may collectively contribute to tracheal cartilage exposure in this patient. In such diseases, detachment of tracheal cartilage causing airway obstruction may lead to asphyxia. This patient had diabetes mellitus with poorly controlled blood glucose. The hyperglycemic environment provides abundant nutrients for fungal growth and proliferation. The functional immunosuppression associated with diabetes also increases the risk of fungal infection. Currently, fungal infections are common in immunocompromised populations [13], and reports of fungal infections in such groups are numerous. However, the manifestation of cartilage detachment due to fungal infection, as seen in this case, is exceedingly rare. Shok Yin Lee reported a case in 2019 where the airway was invaded by fungus following chemotherapy [14], but it did not result in tracheal cartilage ring detachment. Therefore, in immunocompromised individuals, it is crucial to pay attention to airway fungal infections, particularly aspergillus infections. Studies report that the mortality rate of aspergillus infection can be as high as 72.2%. Early diagnosis and prompt initiation of antifungal therapy are key factors for survival [15]. Conclusion The application of modern diagnostic tools such as endoscopy, pathology, and NGS has reduced the challenges in diagnosing and treating pulmonary fungal infections. When Aspergillus infects the tracheobronchial mucosa, it can cause exudative lesions and fibrosis. The associated endotoxins and proteolytic enzymes lead to tissue necrosis and dissolution, potentially involving cartilage and resulting in tracheal cartilage exfoliation. This severe complication is prone to misdiagnosis and carries an inherent risk of asphyxia. This risk underscores the necessity of thorough patient counseling, ensuring they are aware of all potential complications, including cartilage damage, during subsequent care.